100%

Admin

Author Image

Education

Notable awards

Profile

Courses

1
Artificial Intelligence in Echocardiography: Workflow Efficiency & Patient Satisfaction – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s fast-paced clinical environment, it is helpful to understand how ultrasound integrates new artificial intelligence technologies to best serve both physicians and patients. Specifically, how AI can improve patient satisfaction, increase medical professionals’ workflow efficiency, expand scientific knowledge and explore disease prediction models.

Objectives

  • To review the different types of machine learning (ML) techniques
  • To understand how ML algorithms could be incorporated in practice to improve echo lab workflow
  • Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era
  • Understand the potential for AI technology in improving patient satisfaction and clinical outcomes

Target Audience

The content of this SDMD CME Symposium is intended for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 09/10/2022 | Expires: 09/10/2023

Disclosures

Jordan B. Strom, MD, MSc, FACC, FASE

  • Edwards Life Sciences
  • Bracco
  • Ultromics and Heart Sciences

Patricia A. Pellikka, MD, FACC, FAHA, FASE

  • Ultromics LTD
  • American Society of Echo Foundation

Partho Sengupta, MD, DM, FACC, FASE

  • Ultromics LTD
  • Kencor Health
  • RCE Technologies

Faculty

Jordan B. Strom
MD, MSc, FACC, FASE

Harvard Medical School
Boston, MA

 

 

Patricia A. Pellikka
MD, FACC, FAHA, FASE

Mayo Clinic
Rochester, MN

 

 

Partho Sengupta
MD, DM, FACC, FASE

WVU Heart & Vascular Institute
Morgantown, WV

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported in part with unrestricted educational grants provided by:
Bracco Diagnostics Inc. & Lantheus Medical Imaging
We are grateful to our faculty for their expertise and are privileged to work with them.

2
Artificial Intelligence in Echocardiography: Workflow Efficiency & Patient Satisfaction – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s fast-paced clinical environment, it is helpful to understand how ultrasound integrates new artificial intelligence technologies to best serve both physicians and patients. Specifically, how AI can improve patient satisfaction, increase medical professionals’ workflow efficiency, expand scientific knowledge and explore disease prediction models.

Objectives

  • To review the different types of machine learning (ML) techniques
  • To understand how ML algorithms could be incorporated in practice to improve echo lab workflow
  • Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era
  • Understand the potential for AI technology in improving patient satisfaction and clinical outcomes

Target Audience

To review the different types of machine learning (ML) techniques To understand how ML algorithms could be incorporated in practice to improve echo lab workflow Characterize the challenges and opportunities related to the application of AI in echocardiography in the COVID-19 era Understand the potential for AI technology in improving patient satisfaction and clinical outcomes

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 09/10/2022 | Expires: 09/10/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jordan B. Strom, MD, MSc, FACC, FASE

  • Edwards Life Sciences
  • Bracco
  • Ultromics and Heart Sciences

Patricia A. Pellikka, MD, FACC, FAHA, FASE

  • Ultromics LTD
  • American Society of Echo Foundation

Partho Sengupta, MD, DM, FACC, FASE

  • Ultromics LTD
  • Kencor Health
  • RCE Technologies

Faculty

Jordan B. Strom
MD, MSc, FACC, FASE

Harvard Medical School
Boston, MA

 

 

Patricia A. Pellikka
MD, FACC, FAHA, FASE

Mayo Clinic
Rochester, MN

 

 

Partho Sengupta
MD, DM, FACC, FASE

WVU Heart & Vascular Institute
Morgantown, WV

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported in part with unrestricted educational grants provided by:
Bracco Diagnostics Inc. & Lantheus Medical Imaging
We are grateful to our faculty for their expertise and are privileged to work with them.

3
High Relaxivity When its Value makes a Clinically Relevant Difference – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “High Relaxivity: When its Value makes a Clinically Relevant Difference” discusses how high relaxivity contrast can improve brain lesion detection. In addition, we explore how to create a lower-dose dynamic for MR protocols using high relaxivity contrast. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  1. Explain the difference between signal to noise and contrast to noise and the significance of this difference in lesion detection.
  2. Explain how high relaxivity contrast can improve brain lesion detection.
  3. Relate clinical scenarios in which higher relaxivity is likely beneficial and when higher relaxivity may not be as clinically relevant.
  4. Create lower-dose dynamic MR protocols using high relaxivity contrast.

Target Audience

The content of this CME webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Northwest Imaging Forums (NWIF) is accredited by the ACCME to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 09/03/2022 | Expires 09/02/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG

Chief, Division of Emergency Radiology and Teleradiology Director
Magnetic Resonance Services
Professor of Radiology and Neuroradiology
University of Pittsburgh Medical Center
University of Pittsburgh School of Medicine

 

 

 

Howard A. Rowley MD, FACR, FASFNR, FAAN, FAHA, FRANZCR

Joseph Sackett Professor,
Radiology Professor, Radiology,
Neurology, and Neurosurgery
University of Wisconsin
Madison, Wisconsin

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

4
High Relaxivity When its Value makes a Clinically Relevant Difference – CE
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “High Relaxivity: When its Value makes a Clinically Relevant Difference” discusses how high relaxivity contrast can improve brain lesion detection. In addition, we explore how to create a lower-dose dynamic for MR protocols using high relaxivity contrast. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  1. Explain the difference between signal to noise and contrast to noise and the significance of this difference in lesion detection.
  2. Explain how high relaxivity contrast can improve brain lesion detection.
  3. Relate clinical scenarios in which higher relaxivity is likely beneficial and when higher relaxivity may not be as clinically relevant.
  4. Create lower-dose dynamic MR protocols using high relaxivity contrast.

Target Audience

The content of this CE webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This program has been submitted for 1.0 hours of Category A American Registry of Radiologic Technologists (ARRT) credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) Recognized Continuing Education Evaluation Mechanism (RCEEM). This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent  biennium.

Release Date: 09/03/2022 | Expires 09/02/2023

Faculty

Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG

Chief, Division of Emergency Radiology and Teleradiology Director
Magnetic Resonance Services
Professor of Radiology and Neuroradiology
University of Pittsburgh Medical Center
University of Pittsburgh School of Medicine

 

 

 

Howard A. Rowley, MD, FACR, FASFNR, FAAN, FAHA, FRANZCR

Joseph Sackett Professor of Radiology,
Professor of Radiology, Neurology, and Neurosurgery
University of Wisconsin
Madison, Wisconsin

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

5
Hot Topics in CNS for MRI – CE
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Hot Topics in CNS for MRI” discusses the value of high relaxivity for brain cancer detection and evaluation and its possible impact in patient treatment decision-making. In addition, we discuss properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in neuroradiology. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  1. Describe properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in
  2. Discuss the value of high relaxivity for brain cancer detection and evaluation and possible impact in patient treatment decision-making.
  3. Identify gadolinium exposure: which dose to use in which population including patients with lifetime risk of multiple repeated injections g., MS patients and patients for tumor diagnosis and follow-up and at which field strength.
  4. Review safety of GBCAs: perceived vs real differences
  5. Discuss the future of MRI: new agents and new technology (e.g., A.I.) on the horizon

Target Audience

The content of this CE webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This program has been submitted for 1.0 hour of Category A American Registry of Radiologic Technologists (ARRT) credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) Recognized Continuing Education Evaluation Mechanism (RCEEM). This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 09/03/2022 | Expires 09/02/2023

Faculty

Max Wintermark, MD

Chairman of Neuroradiology University of Texas-MD Anderson
Houston, Texas

 

 

 

Howard A. Rowley MD

Joseph Sackett Professor,
Radiology Professor, Radiology,
Neurology, and Neurosurgery University of Wisconsin Madison, Wisconsin

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

6
Hot Topics in CNS for MRI – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This webinar titled “Hot Topics in CNS for MRI” discusses the value of high relaxivity for brain cancer detection and evaluation and its possible impact in patient treatment decision-making. In addition, we discuss properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in neuroradiology. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  1. Describe properties of available GBCAs and how they selectively matter in the selection of an MR contrast agent in
  2. Discuss the value of high relaxivity for brain cancer detection and evaluation and possible impact in patient treatment decision-making.
  3. Identify gadolinium exposure: which dose to use in which population including patients with lifetime risk of multiple repeated injections g., MS patients and patients for tumor diagnosis and follow-up and at which field strength.
  4. Review safety of GBCAs: perceived vs real differences
  5. Discuss the future of MRI: new agents and new technology (e.g., A.I.) on the horizon

Target Audience

The content of this CME/CE live symposium is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Northwest Imaging Forums (NWIF) is accredited by the ACCME to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Release Date: 08/31/2022 | Expires 08/31/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Max Wintermark, MD

Chairman of Neuroradiology University of Texas-MD Anderson
Houston, Texas

 

 

 

Howard A. Rowley MD

Joseph Sackett Professor,
Radiology Professor, Radiology,
Neurology, and Neurosurgery University of Wisconsin Madison, Wisconsin

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

7
Boston Echo Conference – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

Exercise stress echocardiography can assess significant coronary artery disease in patients with no history of CAD and to assess myocardial ischemia in patients with known CAD. In these patients, often, contrast agents are administered. For other indications such as valve diseases and hypertrophic cardiomyopathy, contrast agents are occasionally needed for the improvement of endocardial definition. For these indications, the instrument, settings, and
contrast dosages can be different. Unconventional uses of contrast will be discussed and reviewed in case studies. This course is specifically designed with Sonographers and Cardiologists in mind.

Objectives

  • Review cardiac anatomy and explore how Right Ventricular (RV) assessment requires multiple scanning windows.
  • Review Case Studies.
  • Understand the Principles of Contrast Echo.

Target Audience

The content of this SDMS CME symposium is intended for healthcare professionals including Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

This program has been submitted for approval of 3.5 hours of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 05/30/2022 | Expires: 05/30/23

Faculty

Lanqi Hua, MD,ACS, APCA, RDCS, FASE

Technical Director
Massachusetts General Hospital
Boston, MA

Lauren C. Motola, BS, RDCS, FASE

Adult & Pediatric Cardiac Sonographer
Elliot Hospital
Manchester, NH

 

Jason B. Pereira, MS, RCS

Lead Echosonographer
Heart and Vascular Institute
The Hospital of Central
Connecticut New Britain, CT

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

8
GBCAs: One Fits All or Tailoring? The Experts Convene – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This symposium titled “GBCAs: One Fits All or Tailoring? The Experts Convene” explores societal guidelines in terms of gadolinium administration for neuroimaging, breast and MRA/liver studies in MRI. Our experts discuss practical strategies and implementation of these guidelines in routine clinical practice. We will review strategies on how to address patients’ concerns regarding gadolinium administration as well. The purpose of this symposium is to provide physicians and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  • Review societal guidelines in terms of gadolinium administration for neuroimaging studies in MRI.
  • Understand patient selection and indications for breast MRI while reviewing the technical requirements for contrast-enhanced breast MR imaging.
  • Review the characteristics and safety profile of the currently available Gd-based contrast agents (GBCA) for MRA and liver imaging.

Target Audience

The content of this CME/CE Symposium is intended for healthcare professionals including Radiologists and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, Technologists, and Others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 04/22/2022 | Expires 04/22/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jeffrey Maki MD, PhD

Director MRI & Nuclear Brain Imaging
Professor of Radiology Chief of Abdominal Imaging
University of Colorado Anschutz
Medical Center Denver, Colorado

Max Wintermark, MD

Professor Of Radiology,
Neurology, Neurosurgery And Of Psychiatry And
Behavioral Sciences Stanford
University Medical Center
Stanford, California

Christopher Comstock,
MD, FACR, FSBI

Attending Radiologist, Breast Imaging Section,
Memorial Sloan Kettering
Cancer Center New York, NY

9
GBCAs: One Fits All or Tailoring? The Experts Convene – CE
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Faculty
Description

This symposium titled “GBCAs: One Fits All or Tailoring? The Experts Convene” explores societal guidelines in terms of gadolinium administration for neuroimaging, breast and MRA/liver studies in MRI. Our experts discuss practical strategies and implementation of these guidelines in routine clinical practice. We will review strategies on how to address patients’ concerns regarding gadolinium administration as well. The purpose of this symposium is to provide physicians and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  • Review societal guidelines in terms of gadolinium administration for neuroimaging studies in MRI.
  • Understand patient selection and indications for breast MRI while reviewing the technical requirements for contrast-enhanced breast MR imaging.
  • Review the characteristics and safety profile of the currently available Gd-based contrast agents (GBCA) for MRA and liver imaging.

Target Audience

The content of this CME/CE Symposium is intended for healthcare professionals including Radiologists and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, Technologists, and Others.

Accreditation

This program has been submitted for 1.00 hour of Category A CE ARRT credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) RCEEM. This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 04/22/2022 | Expires 04/22/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Faculty

Jeffrey Maki MD, PhD

Director MRI & Nuclear Brain Imaging
Professor of Radiology Chief of Abdominal Imaging
University of Colorado Anschutz
Medical Center Denver, Colorado

Max Wintermark, MD

Professor Of Radiology,
Neurology, Neurosurgery And Of Psychiatry And
Behavioral Sciences Stanford
University Medical Center
Stanford, California

Christopher Comstock,
MD, FACR, FSBI

Attending Radiologist, Breast Imaging Section,
Memorial Sloan Kettering
Cancer Center New York, NY

10
Level 2 MR Safety for MR Radiologists
Expires After: Does not Expire

Description

This video is designed to be used for annual MR safety training specifically for the radiologist who oversees MRI.

Accreditation

There is no accreditation for this video.

11
GBCA Tolerability: Adverse Events and Differentiating Characteristics – CE
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Description

This webinar titled “GBCA Tolerability: Adverse Events, and Differentiating Characteristics” discusses the basics of gadolinium-based contrast agents(GBCAs), the history of GBCAs, and the safety of GBCA administration in magnetic resonance imaging (MRI). The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  • Understand the basic chemistry of pharmacology of gadolinium-based contrast agents.
  • Discuss differences in GBCAs approved for Neuro use in the US.
  • Review the two forms of acute GBCA reaction: Allergic and Idiosyncratic.
  • Illustrate how gadolinium retention occurs with all of the GBCA’s, is still of unproven clinic significance, and is only visible on T1 MRI following repeated GBCA injections.

Target Audience

The content of this CME/CE Symposium is intended for healthcare professionals including Radiologists and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, Technologists, and Others.

Accreditation

This program has been submitted for approval of 1.50 hours of Category A CE ARRT credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) RCEEM. This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 02/02/2022 | Expires 02/01/2023

Faculty and Planner Disclosures:

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Emanuel Kanal, MD, FACR, FISMRM, MRMD, MRSE, AANG

  • GE Healthcare     Consulting Fee
  • Medtronic             Consulting Fee

John P. Karis, MD, MRMD

  • Bracco Diagnostics Inc.  Consulting Fee
  • Ambra Health –  Founding shareholder, Consultant
  • Philips – Consultant, Speaker

 

Watch video only, no credit Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

12
Update in Contrast MRI of the Liver – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

There is a need to explore the common indications for contrast-enhanced liver MRI. In order to do this, our faculty will review characteristics and safety profiles of the currently available GBCAs including discussing the differences between extracellular and hepatobiliary GBCA options. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  • Review the characteristics and safety profile of the currently available Gd-based contrast agents (GBCA) for MR liver imaging.
  • Understand the differences between extracellular and hepatobiliary GBCA
  • Explore the common indications for contrast-enhanced liver MRI
  • Discuss GBCA enhanced MRI of the liver in both non-cirrhotic and non-oncologic patients.

Target Audience

The content of this CME/CE webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this webinar for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 02/02/2022 | Expires 02/01/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jeffrey Maki MD, PhD

  • Bracco Diagnostics Inc.

Alessandro Furlan, MD

  • Enrda Life Sciences

Faculty

Jeffrey Maki MD, PhD

Director MRI & Nuclear Brain Imaging
Professor of Radiology Chief of Abdominal Imaging
University of Colorado Anschutz
Medical Center Denver, Colorado

Alessandro Furlan MD

Associate Professor Chief – Abdominal
Imaging Division Department of Radiology
University of Pittsburgh
Medical Center
Pittsburgh, Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

13
Update in Contrast MRI of the Liver – CE
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

There is a need to explore the common indications for contrast-enhanced liver MRI. In order to do this, our faculty will review characteristics and safety profiles of the currently available GBCAs including discussing the differences between extracellular and hepatobiliary GBCA options. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

    1. Review the characteristics and safety profile of the currently available Gd-based contrast agents (GBCA) for MR liver imaging.
    2. Understand the differences between extracellular and hepatobiliary GBCA
    3. Explore the common indications for contrast-enhanced liver MRI
    4. Discuss GBCA enhanced MRI of the liver in both non-cirrhotic and non-oncologic patients.

Target Audience

The content of this CME/CE webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.

Accreditation

This program has been submitted for 1.5 hours of Category A CE ARRT credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) RCEEM. This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 02/02/2022 | Expires 02/01/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jeffrey Maki MD, PhD

  • Bracco Diagnostics Inc.

Alessandro Furlan, MD

  • Enrda Life Sciences

Faculty

Jeffrey Maki MD, PhD

Director MRI & Nuclear Brain Imaging
Professor of Radiology Chief of Abdominal Imaging
University of Colorado Anschutz
Medical Center Denver, Colorado

Alessandro Furlan MD

Associate Professor Chief – Abdominal
Imaging Division Department of Radiology
University of Pittsburgh
Medical Center
Pittsburgh, Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

14
GBCA Tolerability: Adverse Events and Differentiating Characteristics – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Description

This webinar titled “GBCA Tolerability: Adverse Events and Differentiating Characteristics” discusses the basics of gadolinium-based contrast agents(GBCAs), the history of GBCAs, and the safety of GBCA administration in magnetic resonance imaging (MRI). The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.

Objectives

  • Understand the basic chemistry of pharmacology of gadolinium-based contrast agents.
  • Discuss differences in GBCAs approved for Neuro use in the US.
  • Review the two forms of acute GBCA reaction: Allergic and Idiosyncratic.
  • Illustrate how gadolinium retention occurs with all of the GBCA’s, is still of unproven clinic significance, and is only visible on T1 MRI following repeated GBCA injections.

Target Audience

The content of this CME/CE Symposium is intended for healthcare professionals including Radiologists and Other Physicians, Radiologic and Imaging Nurses, Facility Managers, Researchers, Technologists, and Others.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.5 hours AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 02/02/2022 | Expires: 02/01/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Emanuel Kanal, MD, FACR, FISMRM, MRMD, MRSE, AANG

  • GE Healthcare     Consulting Fee
  • Medtronic             Consulting Fee

John P. Karis, MD, MRMD

  • Bracco Diagnostics Inc.  Consulting Fee
  • Ambra Health –  Founding shareholder, Consultant
  • Philips – Consultant, Speaker

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

15
Hypersensitivity to Ultrasound Enhancing Agents: Update on ASE Recommendations on Safety and Echo Lab Policy – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Hypersensitivity reactions to the polyethylene glycol component of lipid stabilized UEAs have recently been recognized but are extremely rare. Sonographers, nurses, and physicians involved in the practice of echocardiography require information on related recommended changes to echo laboratory policy involving the use of UEAs. This webinar brings together experts in the field, where they will discuss:

  1. The mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEA’s), including new information implicating hypersensitivity to polyethylene glycol
  2. Established new contraindications to UEAs
  3. New information to laboratory policy for UEAs

Objectives

  • Summarize the mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEAs), including new information implicating hypersensitivity to polyethylene glycol
  • Recognize established and new contraindications to UEAs
  • Translate this new information to laboratory policy for UEAs

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 07/26/2022 | Expires: 07/26/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jonathan R. Lindner MD, FASE, FACC

  • Lantheus Medical Imaging
  • GE Healthcare

Sharon L. Mulvagh MD, FRCPC, FACC, FAHA, FASE

  • No Disclosures

Joan J. Olson B.S, ACS, RDCS, RVT, FASE

  • No Disclosures

Anthony Montanaro MD, FACP, FAAAI, FACAI

  • Merck Regeneron Teva
  • AstraZeneca
  • Avillion

Faculty

Jonathan R. Lindner, MD, FASE, FACC

M. Lowell Edwards
Professor of Cardiology,
Oregon Health and Science
University
Portland, Oregon

 

 

Sharon L. Mulvagh, MD, FRCPC, FACC, FAHA, FASE

Professor of Medicine, Cardiologist,
Dalhousie University,
Emeritus Professor of Medicine,
Cardiovascular Diseases, Mayo Clinic
Halifax, Nova Scotia, Canada

Joan J. Olson, B.S, ACS, RDCS, RVT, FASE

Echocardiography & Nuclear
Imaging Manager
Nebraska Medicine
Omaha, Nebraska

 

Anthony Montanaro, MD, FACP, FAAAI, FACAI

Medical Director of Northwest
Research, Head Division of
Allergy & Immunology, OHSU
Portland, Oregon

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported in part with unrestricted educational grants provided by:
Bracco Diagnostics Inc. & Lantheus Medical Imaging
We are grateful to our faculty for their expertise and are privileged to work with them.

16
Hypersensitivity to Ultrasound Enhancing Agents: Update on ASE Recommendations on Safety and Echo Lab Policy – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Hypersensitivity reactions to the polyethylene glycol component of lipid stabilized UEAs have recently been recognized but are extremely rare. Physicians, sonographers, and nurses involved in the practice of echocardiography require information on related recommended changes to echo laboratory policy involving the use of UEAs. This webinar brings together experts in the field, where they will discuss:

  1. The mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEAs), including new information implicating hypersensitivity to polyethylene glycol
  2. Established new contraindications to UEAs
  3. New information to laboratory policy for UEAs

Objectives

  1. Summarize the mechanisms of hypersensitivity reactions to ultrasound enhancing agents (UEAs), including new  information implicating hypersensitivity to polyethylene glycol
  2. Recognize established and new contraindications to UEAs
  3. Translate this new information to laboratory policy for UEAs

Target Audience

The content of this SDMS CME symposium is intended for sonographers and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 07/26/2022 | Expires: 07/26/2023

Disclosures

Jonathan R. Lindner MD, FASE, FACC

  • Lantheus Medical Imaging
  • GE Healthcare

Sharon L. Mulvagh MD, FRCPC, FACC, FAHA, FASE

  • No Disclosures

Joan J. Olson B.S, ACS, RDCS, RVT, FASE

  • No Disclosures

Anthony Montanaro MD, FACP, FAAAI, FACAI

  • Merck Regeneron Teva
  • AstraZeneca
  • Avillion

Faculty

Jonathan R. Lindner, MD, FASE, FACC

M. Lowell Edwards
Professor of Cardiology,
Oregon Health and Science
University
Portland, Oregon

 

 

Sharon L. Mulvagh, MD, FRCPC, FACC, FAHA, FASE

Professor of Medicine, Cardiologist,
Dalhousie University,
Emeritus Professor of Medicine,
Cardiovascular Diseases, Mayo Clinic
Halifax, Nova Scotia, Canada

Joan J. Olson, B.S, ACS, RDCS, RVT, FASE

Echocardiography & Nuclear
Imaging Manager
Nebraska Medicine
Omaha, Nebraska

 

Anthony Montanaro, MD, FACP, FAAAI, FACAI

Medical Director of Northwest
Research, Head Division of
Allergy & Immunology, OHSU
Portland, Oregon

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported in part with unrestricted educational grants provided by:
Bracco Diagnostics Inc. & Lantheus Medical Imaging
We are grateful to our faculty for their expertise and are privileged to work with them.

17
Contrast Echocardiography Case Studies – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Sonographers and Physicians need up-to-date information to understand the important role of contrast echocardiography for the diagnosis, monitoring, and management of cardiovascular disease. Reliable endocardial border definition is crucial for the assessment of LV wall motion and detection of coronary artery disease (CAD), which can be difficult in some patients. In situations where quality images can only be recorded using special breathing maneuvers, clinicians may find that stress echocardiography with contrast agents is of benefit, particularly in obtaining reliable loops at peak stress. This webinar will present case studies illustrating the use of contrast to improve image quality and diagnostic accuracy in echocardiography.

Objectives

  • How to properly use contrast imaging to evaluate cardiac masses and chest pain.
  • When to use conventional LVO imaging vs. VLMI (very low MI imaging) for different pathology.
  • How to identify cardiac rupture using contrast imaging.
  • How to identify regional wall motion abnormalities and aneurysms using contrast imaging.

Target Audience

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 01/20/2022 | Expires: 01/19/2023

Disclosures

Joan J. Olson, BS, RDCS, RVT, FASE

  • No Disclosures

Jennifer Betz, BS, RDCS, FASE

  • No Disclosures

Faculty

 

Joan J. Olson, BS, RDCS, RVT, FASE

Echocardiography & Nuclear
Imaging Manager
Nebraska Medicine
Omaha, Nebraska

 

 

 

 

Jennifer Betz, BS, RDCS, FASE

Mayo School of Health Sciences
Rochester, MN

 

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

18
Contrast Echocardiography Case Studies – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Sonographers and Physicians need up-to-date information to understand the important role of contrast echocardiography for the diagnosis, monitoring, and management of cardiovascular disease. Reliable endocardial border definition is crucial for the assessment of LV wall motion and detection of coronary artery disease (CAD), which can be difficult in some patients. In situations where quality images can only be recorded using special breathing maneuvers, clinicians may find that stress echocardiography with contrast agents is of benefit, particularly in obtaining reliable loops at peak stress. This webinar will present case studies illustrating the use of contrast to improve image quality and diagnostic accuracy in echocardiography.

Objectives

  • How to properly use contrast imaging to evaluate cardiac masses and chest pain.
  • When to use conventional LVO imaging vs. VLMI (very low MI imaging) for different pathology.
  • How to identify cardiac rupture using contrast imaging.
  • How to identify regional wall motion abnormalities and aneurysms using contrast imaging.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 01/20/2022 | Expires: 01/19/2023

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Joan J. Olson, BS, RDCS, RVT, FASE

  • No Disclosures

Jennifer Betz, BS, RDCS, FASE

  • No Disclosures

Faculty

 

Joan J. Olson, BS, RDCS, RVT, FASE

Echocardiography & Nuclear
Imaging Manager
Nebraska Medicine
Omaha, Nebraska

 

 

 

 

Jennifer Betz, BS, RDCS, FASE

Mayo School of Health Sciences
Rochester, MN

 

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

19
The Treatment of Abdominal Aortic Aneurysm and How Contrast-Enhanced Ultrasound (CEUS) Can Improve Patient Care – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In this webinar, we will cover endovascular aortic aneurysm repair (EVAR) and fenestrated-branched endovascular aortic aneurysm repair (F-BEVAR) for the treatment of aortic aneurysms. We will also explore possible complications of this treatment, highlighting endoleaks. Cases of how the use of contrast-enhanced ultrasound improved images will be presented with a brief explanation describing how the “bubbles” work. Lastly, a dive into the use of ultrasound and contrast-enhanced ultrasound within the vascular surgery practice of the aortic field will be reviewed.

Objectives

  • Introduce the optimal uses of ultrasound and contrast-enhanced ultrasound for aortic pathologies.
  • Discuss the importance and benefits of contrast-enhanced ultrasound compared to CT.
  • Review the limitations of contrast-enhanced ultrasound.
  • Review how contrast-enhanced ultrasound improves vascular practice on treatments of aortic aneurysm.

Target Audience

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 0.5 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 12/28/2021 | Expires: 12/28/2022

Disclosures

Carla K. Scott, MD

  • No Disclosures

Faculty

Carla K. Scott, MD

Vascular Surgeon (SBACV board certified), Brazil
Ultrasound Doppler Specialist, Brazil
UT Southwestern Research Fellow, Dallas, Texas, US

 

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

20
The Treatment of Abdominal Aortic Aneurysm and How Contrast-Enhanced Ultrasound (CEUS) Can Improve Patient Care – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In this webinar, we will cover endovascular aortic aneurysm repair (EVAR) and fenestrated-branched endovascular aortic aneurysm repair (F-BEVAR) for the treatment of aortic aneurysms. We will also explore possible complications of this treatment, highlighting endoleaks. Cases of how the use of contrast-enhanced ultrasound improved images will be presented with a brief explanation describing how the “bubbles” work. Lastly, a dive into the use of ultrasound and contrast-enhanced ultrasound within the vascular surgery practice of the aortic field will be reviewed.

Objectives

  • Introduce the optimal uses of ultrasound and contrast-enhanced ultrasound for aortic pathologies.
  • Discuss the importance and benefits of contrast-enhanced ultrasound compared to CT.
  • Review the limitations of contrast-enhanced ultrasound.
  • Review how contrast-enhanced ultrasound improves vascular practice on treatments of aortic aneurysm.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 0.5 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 12/28/2021 – Expires: 12/28/2022

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Carla K. Scott, MD

  • No Disclosures

Faculty

Carla K. Scott, MD

Vascular Surgeon (SBACV board certified), Brazil
Ultrasound Doppler Specialist, Brazil
UT Southwestern Research Fellow, Dallas, Texas, US

 

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

21
Stop the Right Heart Struggles: RV Opacification– CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

This webinar will discuss processes needed to evaluate the right ventricle (RV) of the heart, assess the challenges with various patient populations, and explore the advantages of using ultrasound enhancing agents (UEAs) for a more comprehensive diagnosis. Using UEAs to enhance RV echocardiography, as established by various case studies, has shown to be effective in evaluating the right ventricular size, function, and wall motion to a greater degree than without. Current trends will be reviewed and real-life case examples will be presented to enhance patient care.

Objectives

  • Describe how size and function play pivotal roles in the prognosis of several cardiac diseases.
  • Discuss the reasons why echocardiography should be the most frequently used imaging modality.
  • Review cardiac anatomy and explore how Right Ventricular (RV) assessment requires multiple scanning windows.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons) and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.   Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 12/28/2021 | Expires: 12/28/2022

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jason B. Pereira, MS, RCS

  • Clinical Specialist for Lantheus Medical Diagnostic Imaging Solutions

Faculty

Jason B. Pereira, MS, RCS

Research Echosonographer
Yale-New Haven Health System
New Haven, CT

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

22
Stop the Right Heart Struggles: RV Opacification – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

This webinar will discuss processes needed to evaluate the right ventricle (RV) of the heart, assess the challenges with various patient populations, and explore the advantages of using ultrasound enhancing agents (UEAs) for a more comprehensive diagnosis. Using UEAs to enhance RV echocardiography, as established by various case studies, has shown to be effective in evaluating the right ventricular size, function, and wall motion to a greater degree than without. Current trends will be reviewed and real-life case examples will be presented to enhance patient care.

Objectives

  • Describe how size and function play pivotal roles in the prognosis of several cardiac diseases.
  • Discuss the reasons why echocardiography should be the most frequently used imaging modality.
  • Review cardiac anatomy and explore how Right Ventricular (RV) assessment requires multiple scanning windows.

Target Audience

This program has been designed for sonographers and other healthcare  professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Date: 12/28/2021 | Expires: 12/28/2022

Disclosures

Jason B. Pereira, MS, RCS

  • Clinical Specialist for Lantheus Medical Diagnostic Imaging Solutions

Faculty

Jason B. Pereira, MS, RCS

Research Echosonographer
Yale-New Haven Health System
New Haven, CT

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

23
Application of Data Analytics in Noninvasive Laboratory Operations, A Community Perspective – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s current clinical environment, it is helpful to understand the challenges in integrating community health systems. Specifically, how to improve services such as Stress echocardiography Ultrasound Enhancing Agents (UEAS), perfusion, valvular/hemodynamic; in addition to other services of transesophageal, transthoracic, and peripheral vascular. In this webinar Dr. Culp will discuss his experience over the past 5 years creating a non-invasive quality program that leverages simple data entry to make informed operational decisions on budgetary and quality issues within the lab thus increasing overall community care.

Objectives

  1. Describe the use of structured reporting as a tool for quality assurance with limited resources.
  2. Apply quality assurance processes to implement advanced imaging techniques within an echo laboratory.
  3. Describe the basic budgetary components of echo laboratory operations.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education.  Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 08/9/2021 | Expires 08/9/2022

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content.  Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Benjamin Culp, MD, FASE, RPVI

  • No Disclosures

Faculty

Benjamin Culp, MD, FASE, RPVI


Non-invasive Cardiologist Ballad CVA Heart Institute
Head of Non-invasive Imaging Center of Excellence

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

24
Application of Data Analytics in Noninvasive Laboratory Operations, A Community Perspective – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s current clinical environment, it is helpful to understand the challenges in integrating community health systems. Specifically, how to improve services such as Stress echocardiography Ultrasound Enhancing Agents (UEAS), perfusion, valvular/hemodynamic; in addition to other services of transesophageal, transthoracic, and peripheral vascular. In this webinar Dr. Culp will discuss his experience over the past 5 years creating a non-invasive quality program that leverages simple data entry to make informed operational decisions on budgetary and quality issues within the lab thus increasing overall community care.

Objectives

  1. Describe the use of structured reporting as a tool for quality assurance with limited resources.
  2. Apply quality assurance processes to implement advanced imaging techniques within an echo laboratory.
  3. Describe the basic budgetary components of echo laboratory operations.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 0.75 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date:  08/9/2021 | Expires 08/9/2022

Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content.  Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Benjamin Culp, MD, FASE, RPVI

  • No Disclosures

Faculty

Benjamin Culp, MD, FASE, RPVI


Non-invasive Cardiologist Ballad CVA Heart Institute
Head of Non-invasive Imaging Center of Excellence

Video Only – Click Here

If you wish to receive credit, please click on the Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

25
Kanal’s MRMD/MRSO Safety Training Virtual Conference
Expires After: Does not Expire









Previous
Next
Program Description
Schedule
Speaker
Accreditation
Disclosures
Program Description

In an effort to provide Physicians, Technologists, and other course attendees with current information and data to make informed decisions in their clinical settings, this symposium covers several objectives. These include teaching and reviewing the basic principles underlying the potential areas of safety concern involved in the MR imaging process and magnetic resonance environment. In addition, defining the thought process algorithms for assessing whether a patient/device/implant/ foreign object can safely undergo MR imaging, and familiarizing the attendee with medico-legal considerations associated with MR safety.

Schedule

Sunday – Day 1 (4.0 Hours)
2:50
3:00
5:00
7:00 pm
Opening Announcements – Matt Wilson
Introduction, MRMD, MRSO, MRSE
Static Magnetic Fields Part I, II
End of Session
Monday – Day 2 (8.0 Hours)
7:20
7:30
8:30
9:30
10:00
11:00
12:00
1:15
2:15
3:15
3:45
4:45
5:45
Opening Announcements – Matt Wilson
Static Magnetic Fields Part III
Static Magnetic Fields Part IV
Break
Static Magnetic Fields Part V
RF Magnetic Fields Part I
Lunch on Your Own
RF Magnetic Fields Part II
RF Magnetic Fields Part III
Break
RF Magnetic Fields Part IV
RF Magnetic Fields Part V
End of Session
Tuesday – Day 3 (8.0 Hours)

7:20
7:30
8:30
9:30
10:00
11:00
12:00
1:15
2:15

3:15
3:45
4:45
5:45

Opening Announcements – Matt Wilson
Gradient Magnetic Fields Part I
Gradient Magnetic Fields Part II
Break
Safety of Gadolinium-Based Contrast Agents
Cryogen Safety Considerations
Lunch on Your Own
Implant Safety: Clinical Application and Decision Making Part I
Implant Safety: Kanal’s MR Safety Implant Risk Assessment
app: Decision tree review and utilization
Break
Implant Safety: Clinical Application and Decision Making Part II
Review of Submitted Questions
End of Session
Wednesday – Day 4 (4.0 Hours)
7:20
7:30

8:30
9:30
10:00
11:00
12:00

Opening Announcements – Matt Wilson
Product labeling and off-label imaging:
The FDA does not approve uses of drugs/devices
Legal Considerations: Part I
Break
Legal Considerations: Part II
Legal Considerations: Part III
End of Session

Speaker

Emanuel Kanal, MD, FACR, FISMRM, MRMD/SE, AANG

Director, Magnetic Resonance Services Professor of Radiology and Neuroradiology

Dr. Kanal has been involved in researching and teaching the world about magnetic resonance (MR) safety issues for more than 30 years, since the introduction of MRI as a clinical diagnostic tool. Having chaired the first magnetic resonance safety committee ever created, he also chaired numerous other MR safety committees and has been continually involved in and/or leading MR safety initiatives ever since. These include, among others, having chaired the MR Safety Committee for the American College of Radiology from its inception in 2001 until the summer of 2012, being awarded fellowship in the American College of Radiology as well as the International Society of Magnetic Resonance in Medicine, and being named a Special Government Employee to the Food and Drug Administration on MR safety issues for both the Division of Medical Imaging and Hematology Products/Drug Safety group (of the Office of Surveillance and Epidemiology) regarding magnetic resonance contrast agents as well as the FDA Center for Devices and Radiological Health regarding all matters relating to magnetic resonance safety.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of The Northwest Imaging Forums, Inc. (NWIF). The Northwest Imaging Forums, Inc. is accredited by the ACCME to provide continuing medical education for physicians. The Northwest Imaging Forums, Inc. designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses may claim credit for activities approved for AMA PRA Category 1 Credits ™ in most states, for up to 50% of the nursing requirement for recertification. This activity is designated for up to 24.0 AMA PRA Category1 Credits ™.

This MRI program has been submitted for approval of 24 hours of category A CE technologist credit as designated by The Society for MR Radiographers & Technologists (SMRT) RCEEM. ARRT regulations state that an individual may not repeat a live activity for credit if it was reported in the same or any subsequent biennium. To receive the maximum amount of credit hours, you must attend all sessions. Verification of attendance policies will be in place for each lecture. This meeting has applied to CAMPEP for approval of 24 MPCEC (Medical Physics Continuing Education Credit) hours.

Disclosures

  • Emanuel Kanal, MD, FACR, FISMRM, MRMD, MRSE, AANG
    • General Electric Healthcare – Speaking Fee
    • Bracco Diagnostics Inc. – Speaking Fee


Claim Your Credit


Zoom FAQ


Meeting Evaluation


Agenda


Decision Tree PDF

26
Non-MR Personnel
Expires After: Does not Expire

Description
Target Audience
Accreditation
Sample
Description

This video is designed to assist sites in providing MR safety education for non- MRI personnel. The video address the importance of access restrictions to the MRI environment and MR safety screening for patients and support personnel.

Target Audience

Specifically designed for MR departments to use as an education tool for all hospital staff (ie non-MR personnel).

Accreditation

No-Accreditation

Sample

27
MR Safety for First Responders
Expires After: Does not Expire

Description Accreditation Sample Description

This video is designed to assist sites in providing MR safety training for first responders (in particular firefighters and police officers).  The main focus is on the dangers associated with the static field and quenching the magnet.  Importance of MRI personnel control of the environment is also emphasized.  

Accreditation

There is not accreditation for this video.

Sample

28
Multimodality Imaging for Assessment of Left Ventricular Assist Device (LVAD) and the Role of Contrast Echocardiography – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s current clinical environment, it is helpful to understand echocardiographic assessment of Left Ventricular Assist Devices. Specifically, how to evaluate Left Ventricular Assist Device (LVAD) complications using echocardiography and recognize the role of CT in evaluation of LVAD complications. There is a need to provide case review for better understanding of echocardiographic assessment of LVAD and how it can increase patient care images. This webinar will cover the role of both contrast echocardiography and CT in evaluation of LVAD.

Objectives

  1. Understand when, why, and how to use Ultrasound Enhancing Agents (UEAs)
  2. Understand when to use UEAs in the imaging of patients with LVADs
  3. Discuss tips and tricks for sonographers in LVAD imaging
  4. Understand echocardiographic assessment of LVAD
  5. Evaluate LVAD complications using echocardiography
  6. Recognize the role of CT in evaluation of LVAD complications

Target Audience

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 7/15/2021 | Expires: 7/15/2022

Disclosures

Dinesh H. Jagasia, MD

  • No Disclosures


Beth Hartzel, RDCS

  • No Disclosures

Faculty

Dinesh H. Jagasia, MD

Professor of Clinical Medicine
Division of Cardiology
Perelman School of Medicine
University of Pennsylvania

 

 

 

Beth Hartzel, RDCS

Cardiac Sonographer
Perelman School of Medicine
University of Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the 
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

29
Multimodality Imaging for Assessment of Left Ventricular Assist Device (LVAD) and the Role of Contrast Echocardiography – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In today’s current clinical environment, it is helpful to understand echocardiographic assessment of Left Ventricular Assist Devices. Specifically, how to evaluate Left Ventricular Assist Device (LVAD) complications using echocardiography and recognize the role of CT in evaluation of LVAD complications. There is a need to provide case review for better understanding of echocardiographic assessment of LVAD and how it can increase patient care images.  This webinar will cover the role of both contrast echocardiography and CT in evaluation of LVAD.

Objectives

  1. Understand when, why, and how to use Ultrasound Enhancing Agents (UEAs)
  2. Understand when to use UEAs in the imaging of patients with LVADs
  3. Discuss tips and tricks for sonographers in LVAD imaging
  4. Understand echocardiographic assessment of LVAD
  5. Evaluate LVAD complications using echocardiography
  6. Recognize the role of CT in evaluation of LVAD complications

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including,but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons)

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 1.0 hour AMA PRA Category 1 Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.

Release Date: 7/15/2021 | Expires: 7/15/2022

Disclosures

Dinesh H. Jagasia, MD

  • No Disclosures


Beth Hartzel, RDCS

  • No Disclosures

Faculty

Dinesh H. Jagasia, MD

Professor of Clinical Medicine
Division of Cardiology
Perelman School of Medicine
University of Pennsylvania

 

 

 

Beth Hartzel, RDCS

Cardiac Sonographer
Perelman School of Medicine
University of Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the 
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

30
Contrast in the Time of Cardio-Oncology – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In this webinar we discuss the when and why to use ultrasound enhancing agents (UEAs). This includes when two or more LV segments cannot be visualized adequately for the assessment of LV function (LVEF and RWM assessment) and/or in settings in which the study indication requires accurate analysis of RWMA (JASE 2018). Current information on safety and optimization is discussed and we explore Cardio-Oncology and how best to monitor cardiotoxicity. Lastly, we cover current updates of UEA roles in the evaluation of masses including perfusion techniques.

Objectives

  1. When, why, and how should I use ultrasound enhancing
    agents?

    1. Current recommendations
    2. Safety
    3. Optimization
  2. Cardio-Oncology
    1. What is it? Why is it important?
    2. What imaging should I use to monitor for cardiotoxicity?
      • 2D, 3D, ultrasound enhancing agents
    3. Usefulness of Strain
  3. UEA for mass perfusion
    1. Thrombus vs Tumor?
    2. Optimizing perfusion techniques

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons)

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 7/7/2021 | Expires: 7/7/2022

Disclosures

Rupal O’Quinn, MD, FACC

  • Nothing to Disclose


Michelle McGovern, RDCS

  • Nothing to Disclose

Faculty

Rupal O’Quinn, MD, FACC

Director of Cardio-Oncology
Penn Presbyterian Medical Center
Assistant Professor of Clinical Medicine
Perelman School of Medicine
University of Pennsylvania

Michelle McGovern, RDCS

Echocardiography Lab Technical Director
Perelman Center for Advanced Medicine
Hospital of the University of Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

31
Contrast in the Time of Cardio-Oncology – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

In this webinar we discuss the when and why to use ultrasound enhancing agents (UEAs). This includes when two or more LV segments cannot be visualized adequately for the assessment of LV function (LVEF and RWM assessment) and/or in settings in which the study indication requires accurate analysis of RWMA (JASE 2018). Current information on safety and optimization is discussed and we explore Cardio-Oncology and how best to monitor cardiotoxicity. Lastly, we cover current updates of UEA roles in the evaluation of masses including perfusion techniques.

Objectives

  1. When, why, and how should I use ultrasound enhancing
    agents?
    1. Current recommendations
    2. Safety
    3. Optimization
  2. Cardio-Oncology
    1. What is it? Why is it important?
    2. What imaging should I use to monitor for cardiotoxicity?
      • 2D, 3D, ultrasound enhancing agents
    3. Usefulness of Strain
  3. UEA for mass perfusion
    1. Thrombus vs Tumor?
    2. Optimizing perfusion techniques

Target Audience

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 0.75 SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 7/7/2021 | Expires: 7/7/2022

Submitted for approval of 0.75 SDMS CME Credit Category AE

Disclosures

Rupal O’Quinn, MD, FACC

  • Bracco – honoraria for unrestricted educational conference (ROQ and MM) and consulting in 2018 (ROQ)
  • Discussion of off-label use of ultrasound enhancing agents


Michelle McGovern, RDCS

  • No Disclosures

Faculty

Rupal O’Quinn, MD, FACC

Director of Cardio-Oncology
Penn Presbyterian Medical Center
Assistant Professor of Clinical Medicine
Perelman School of Medicine
University of Pennsylvania

 

Michelle McGovern, RDCS

Echocardiography Lab Technical Director
Perelman Center for Advanced Medicine
Hospital of the University of Pennsylvania

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

32
Microbubbles In Practice: Safety, Efficacy, and the Use of Ultrasound Enhancing Agents in the Clinic – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

There is a need to provide high quality and timely, clinically relevant cardiovascular education. In an effort to provide an overview of UEAs and the types of UEA available in the United States; we will review the historical safety data on UEAs. Discuss current approaches toward adverse reactions. Evaluate indications for UEA use and evidence base for efficacy in practice. This will provide Physicians and Sonographers with current information and data to make informed decisions in their clinical settings.

Objectives

  • Review the efficacy and cost-effectiveness of UEAs in the ED and ICU
  • Understand the best practices for use of UEAs in echocardiography laboratories and the role of decision aides
  • Review billing/coding for UEA use in echocardiography

Target Audience

This program has been designed for sonographers with an interest in cardiac imaging and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 0.75 SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 6/19/2021 | Expires: 6/19/2022

Submitted for approval of 0.75 SDMS CME Credit Category AE

Disclosures

Jordan Strom, MD, MSc, FACC, FASE

  • Philips Healthcare – Consultant
  • Edwards Lifesciences – Grant Funding

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Harvard Medical School
Boston, MA

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them. 

33
Microbubbles In Practice: Safety, Efficacy, and the Use of Ultrasound Enhancing Agents in the Clinic – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

There is a need to provide high quality and timely, clinically relevant cardiovascular education. In an effort to provide an overview of UEAs and the types of UEA available in the United States; we will review the historical safety data on UEAs. Discuss current approaches toward adverse reactions. Evaluate indications for UEA use and evidence base for efficacy in practice. This will provide Physicians and Sonographers with current information and data to make informed decisions in their clinical settings.

Objectives

  • Review the efficacy and cost-effectiveness of UEAs in the ED and ICU
  • Understand the best practices for use of UEAs in echocardiography laboratories and the role of decision aides
  • Review billing/coding for UEA use in echocardiography

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, and vascular surgeons), and other healthcare professionals involved in echocardiography.

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.

Valid from 06/19/2020 – 06/19/2022

Faculty and Planner Disclosures:

In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME/CE activity. The planner has nothing to disclose.

Disclosures

Jordan Strom, MD, MSc, FACC, FASE

  • Philips Healthcare – Consultant
  • Edwards Lifesciences – Grant Funding

Faculty

Jordan B. Strom, MD, MSc, FACC, FASE

Harvard Medical School
Boston, MA

Video only –  Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them. 

34
Ultrasound Enhancing Agents In the COVID-19 Era: Protocols, Safety, & Impact – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Q&A
Faculty
Description

The current COVID-19 pandemic has raised interest in whether there are changes in either the role or safety of ultrasound enhancing agents (UEAs) in echocardiography. This Webinar from experts in the practice of contrast echocardiography will address:

  1. The impact of UEAs in patients with known or suspected COVID-19.
  2. Modifications to standard protocols for performing contrast ultrasound on patients who are in high-risk isolation settings.
  3. Safety of UEAs in patients who are critically ill or who are known to have COVID-19.

Objectives

  1. Recognize situations where ultrasound enhancing agents (UEAs) are likely to have a clinical impact on the general population and on patients with known or suspected COVID-19.
  2. Be able to apply procedural modifications for efficient and safe use of (UEAs) in COVID-19 patients who are in isolation and at high risk for transmitting the disease.
  3. Understand the biologic basis underlying safety of (UEAs) and how they apply to the COVID-19 setting.

Target Audience

This program has been designed for physicians with an interest in cardiac imaging (including, but not limited to, cardiologists, interventional cardiologists, cardiac, thoracic, and vascular surgeons), nurses, and other healthcare professionals involved in echocardiography who are looking for AMA PRA Category 1 Credit(s)TM

Accreditation

This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education. Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. NWIF designates this live activity for a maximum of 2.0. AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Available from 5-7-2020 – 5-7-2022

2.0 AMA PRA Category 1 Credits™

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jonathan R. Lindner, MD, FACC, FASE

  • Nothing to disclose.

 

Thomas R. Porter, MD, FACC, FASE

  • Speaker: Northwest Imaging Forums
  • Consultant: Lantheus Medical
  • Research Equipment Support: Philips Healthcare

 

Michelle Bierig, PhD, ACS, RDCS, RCS, CPHQ, FASE, AACC – reported no relevant relationships with entities producing health care goods or services

Q&A

Faculty

Jonathan R. Lindner, MD, FACC, FASE

M. Lowell Edwards Professor of Cardiology,
Oregon Health and Science University
Portland, Oregon

 

Thomas R. Porter, MD, FACC, FASE

Professor of Medicine
Theodore F. Hubbard Distinguished Chair of Cardiology
University of Nebraska Medical Center
Division of Cardiovascular Medicine – Omaha, Nebraska

 

Michelle Bierig
PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

Director, Cardiovascular at Hillcrest South
Hillcrest Healthcare System
Tulsa, Oklahoma

In Cooperation with

Watch video only, no credit Click Here

To claim your credit please click on the Take this Course button above.
Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

35
Ultrasound Enhancing Agents In the COVID-19 Era: Protocols, Safety, & Impact – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Q&A
Faculty
Description

The current COVID-19 pandemic has raised interest in whether there are changes in either the role or safety of ultrasound enhancing agents (UEAs) in echocardiography. This Webinar from experts in the practice of contrast echocardiography will address:

  1. The impact of UEAs in patients with known or suspected COVID-19.
  2. Modifications to standard protocols for performing contrast ultrasound on patients who are in high-risk isolation settings.
  3. Safety of UEAs in patients who are critically ill or who are known to have COVID-19.

Objectives

  1. Recognize situations where ultrasound enhancing agents (UEAs) are likely to have a clinical impact on the general population and on patients with known or suspected COVID-19.
  2. Be able to apply procedural modifications for efficient and safe use of (UEAs) in COVID-19 patients who are in isolation and at high risk for transmitting the disease.
  3. Understand the biologic basis underlying safety of (UEAs) and how they apply to the COVID-19 setting.

Target Audience

This program has been designed for sonographers, and other healthcare professionals involved in echocardiography.

Accreditation

This program has been submitted for approval of 0.75 SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Available from 5/7/2022 – 5/7/2023

Submitted for approval of 0.75 SDMS CME Credit Category AE

 

As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.

Disclosures

Jonathan R. Lindner, MD, FACC, FASE

  • NIH: R01-HL0178610, R01-HL130046, and P51-OD011092
  • NASA: 18-18HCFBP_2-0009
  • Investigator-initiated research grants from Lantheus, Ekos, GE

Thomas R. Porter, MD, FACC, FASE

  • Speaker: Northwest Imaging Forums
  • Consultant: Lantheus Medical
  • Research Equipment Support: Philips Healthcare

Michelle Bierig, PhD, ACS, RDCS, RCS, CPHQ, FASE, AACC – reported no relevant relationships with entities producing health care goods or services.

Q&A

Faculty

Jonathan R. Lindner, MD, FACC, FASE

M. Lowell Edwards Professor of Cardiology,
Oregon Health and Science University
Portland, Oregon

 

Thomas R. Porter, MD, FACC, FASE

Professor of Medicine
Theodore F. Hubbard Distinguished Chair of Cardiology
University of Nebraska Medical Center
Division of Cardiovascular Medicine – Omaha, Nebraska

 

Michelle Bierig
PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

Director, Cardiovascular at Hillcrest South
Hillcrest Healthcare System
Tulsa, Oklahoma

In Cooperation with

Watch video only, no credit Click Here

To claim your credit please click on the Take this Course button above.
Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them.

36
Optimal Imaging Modalities for Today’s Practice in Ultrasound-Enhanced Echocardiography – CME
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Clinicians have shown a growing interest in CEUS for diagnostic use and treatment monitoring in the clinical setting, due to new indications and the expansion of CEUS subjective and objective analytical capabilities. Therefore, there is a need to provide up to date information to clinicians on Clinical use of Ultrasonic Enhancing Agents (UEAs) in Echocardiography. Additionally, UEAs and Low Mechanical Index techniques will be explored with emphasis on how to implement these techniques in everyday practice.

Objectives

  1. Discuss Clinical use of Ultrasonic Enhancing Agents (UEAs) in Echocardiography.
  2. Describe UEAs and Low Mechanical Index Modalities.
  3. Discuss How Ultrasound Interacts with Microbubbles to Produce Signal.

Target Audience

The content of this CME webinar is intended for healthcare professionals including Cardiologists, Echocardiographers and Other Physicians, Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Accreditation

Physicians: The Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Northwest Imaging Forums designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All CME course participants are required to pass an online test with a minimum score of 70% in order to be awarded credit.  All CME course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.

AMA PRA Category 1 Credit(s)TM for these programs may be claimed until September 19, 2021.
This CME activity was planned and produced by The Northwest Imaging Forums.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

Release Date: 10/16/2021 | Expires: 10/16/2022

AVAILABLE CREDIT – 1.0 AMA PRA Category 1 Credit

Disclosures

Dr. Thomas R. Porter, MD, FACC, FASE
has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Philips Healthcare

Dr. Sanjiv Kaul, MD, FACC, FASE, FAHA, FRCP
has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Bracco Diagnostics, Inc
  • Ultromics

Dr. Michelle Bierig, PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

  • Reported no relevant relationships with entities producing health care goods or services.

Faculty

Thomas R. Porter, MD, FACC, FASE

Professor of Medicine
Theodore F. Hubbard Distinguished Chair of Cardiology
University of Nebraska Medical Center
Division of Cardiovascular Medicine – Omaha, Nebraska

 

Sanjiv Kaul, MD, FACC, FASE, FAHA, FRCP

Ernest C. Swigert Endowed Chair of Cardiology
Professor of Medicine and Radiology
Oregon Health And Science University
Portland, Oregon

Michelle Bierig, PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

Director, Cardiovascular at Hillcrest South
Hillcrest Healthcare System
Tulsa, OK

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them. 

37
Optimal Imaging Modalities for Today’s Practice in Ultrasound-Enhanced Echocardiography – SDMS
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Disclosures
Faculty
Description

Clinicians have shown a growing interest in CEUS for diagnostic use and treatment monitoring in the clinical setting, due to new indications and the expansion of CEUS qualitative and quantitative analytical capabilities. Therefore, there is a need to provide up to date information to clinicians on Clinical use of Ultrasonic Enhancing Agents (UEAs) in Echocardiography. Additionally, UEAs and Low Mechanical Index techniques will be explored with emphasis on how to implement these techniques in everyday practice.

Objectives

  1. Discuss Clinical Use of Ultrasonic Enhancing Agents (UEAs) in Echocardiography.
  2. Describe UEAs and Low Mechanical Index Modalities.
  3. Discuss How Ultrasound Interacts with Microbubbles to Produce Signal.

Target Audience

The content of this SDMS webinar is intended for healthcare professionals including Sonographers, Radiologic and Imaging Nurses, Facility Managers, Researchers, and Others.

Accreditation

This program has been submitted for approval of 1.0 hour of SDMS CME Credit Category AE by the Society of Diagnostic Medical Sonographers (SDMS).

Release Date: 10/16/2021 | Expires: 10/16/2022

AVAILABLE CREDIT

1.0 hour of Sonographer SDMS CME Credit Category AE

Disclosures

Dr. Thomas R. Porter, MD, FACC, FASE
has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Philips Healthcare

Dr. Sanjiv Kaul, MD, FACC, FASE, FAHA, FRCP
has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Bracco Diagnostics, Inc
  • Ultromics

Dr. Michelle Bierig, PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

  • Reported no relevant relationships with entities producing health care goods or services.

Faculty

Thomas R. Porter, MD, FACC, FASE

Professor of Medicine
Theodore F. Hubbard Distinguished Chair of Cardiology
University of Nebraska Medical Center
Division of Cardiovascular Medicine – Omaha, Nebraska

 

Sanjiv Kaul, MD, FACC, FASE, FAHA, FRCP

Ernest C. Swigert Endowed Chair of Cardiology
Professor of Medicine and Radiology
Oregon Health And Science University
Portland, Oregon

Michelle Bierig, PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC

Director, Cardiovascular at Hillcrest South
Hillcrest Healthcare System
Tulsa, OK

Video Only – Click Here

If you wish to receive credit, please click on the
Take this Course button above.

Supported by an Educational Grant from Bracco Diagnostics Inc.
We are grateful to our faculty for their expertise and are privileged to work with them. 

38
MRI Safety: Level 2 MR Personnel Video Only (Non-CE)
Expires After: 1 year

Description Objectives Target Audience Accreditation Sample Description

This MR safety video (approximately 50 minutes in length) is produced specifically for MR Level 2 Personnel as defined by the ACR Guidance Document on MR Safe Practices: 2013. The major topics covered in this video include:

  • Personnel designation
  • MR safety zones and access control
  • Static field • Gradient (time-varying) magnetic fields
  • Radio frequency (RF) fields
  • Spatial gradient fields
  • Patients with implants and/or devices
  • Labeling
  • Conditions of use (including B1+rms)
  • Managing patient warming
  • Preventing thermal injuries
  • Patient and non-patient screening
  • Quench
  • Medical emergencies in the MRI environment
  • Managing the claustrophobic or anxious patient

 

This video program is intended to satisfy annual education requirements

Objectives

  • Define Level 1 and Level 2 MR personnel
  • Define MR safety Zones III and IV
  • Describe the procedures and documentation associated with screening non-MR personnel
  • Describe the recommendations of both the ACR and Joint Commission with regard to screening patients
  • Describe the importance of patients being dressed in MR appropriate attire prior to undergoing and MR procedure
  • Describe how to minimize the risk to patients with regard to RF burns
  • Name several methods to manage SAR during an MR procedure
  • Describe the importance of monitoring patients and how to prepare for medical emergencies
  • Name and describe the current labeling terminology for implants and devices
  • Describe safety issues related to a quench
  • Name the major acute and chronic gadolinium-based contrast media adverse events
  • Describe techniques which can minimize patient anxiety

Target Audience

The content of this Contrast Enhanced MRI Program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI Technologists, Imaging Nurses, MRI Researchers, and Others.

Accreditation

This program has no Category A CE credit assigned.

Sample

Sample Handout: MR Safety Level 2 Personnel Sample

 

 

39
MR Registry Prep Series
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Sample
Description

The MRI Registry Prep series is authored by Bill Faulkner, a well-known MRI consultant, author and MRI educator.   Topics in this series include: MR Hardware, Safety, Basic Principles of MRI, MR Image Contrast, Pulse Sequences, MR Data Acquisition, Imaging Options and Image Quality, MRA, Diffusion and Perfusion.  In addition, This MR Registry Prep series consists of 6 detailed videos, designed for the MR Technologist who are studying for the MR Certification Exam.  This series will cover the majority of physics-based topics that are on the MR Certification Exam. The viewer must achieve a score of 75% on all quizzes and view all videos to receive a certificate of completion.

MR Registry Prep Series Topics include:

  • MR Hardware
  • MR Safety
  • Basic MR Principles
  • Relaxation and MR Image Contrast
  • Pulse Sequences
  • MR Data Acquisition
  • Imaging Options
  • MR Image Quality
  • Formulas and Calculations
  • MRA
  • Diffusion and Perfusion

Objectives

The series objective is to provide the participant with basic knowledge as it pertains to clinical MRI, in addition to helping them prepare to sit for the MRI certification exam.

Target Audience

  • Technologists interested in MRI.
  • Technologists who have never had any formal education in MRI principles.
  • Molecular Imaging Technologists or CT Technologists who may be cross-training into MRI.
  • Technologists who are preparing for the ARRT or ARMRIT MR certification exams.

Accreditation

This program has been approved for 6.0 hour of Category A CE credit as designated by the Society for MR Radiographers & Technologists (SMRT) RCEEM. 

Please Note:  If This activity was previously offered within a combined CE Module it cannot be used again in this or any subsequent biennium. Additionally, this activity may be available in multiple formats or from different sponsors.  ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 8/27/2020 Expiration Date: 8/26/2022

Sample

40
MRI Safety Level 1 MR Personnel
Expires After: Does not Expire

Description Objectives Sample Description

This 1 hour comprehensive course is designed for medical professionals requiring Level 1 certification for working within the MR Environment. The course explains what the American College of Radiology (ACR) is and its role in creating guidelines for medical facilities. All of the various roles for medical staff will be discussed with an emphasis on Level 1 roles and responsibilities. MR Zoning and its importance along with reasoning for controlled access into various areas of MR will be defined. The importance of MR Screening of both patients and medical professionals will be discussed. Finally, the difference between near incidents and actual incidents will be differentiated and examples of MR Safety accidents will be reviewed.

Objectives

  • State what the American College of Radiology (ACR) is and their Guidelines
  • Define roles and responsibilities with a concentration on Level 1 personnel
  • Create an understanding of MR zoning and controlled access into Zone III
  • Explain the importance of MR Screening of all staff and patients
  • Inform Level 1 concerns for MR Safety as related to patients and personnel
  • Show examples of MR Safety incidents

Sample

Sample handout:   MR Safety Level 1 Personnel Sample

41
MRI Safety: Level 2 MR Personnel
Expires After: Does not Expire

Description
Objectives
Target Audience
Accreditation
Sample
Description

This MR safety video (approximately 50 minutes in length) is produced specifically for MR Level 2 Personnel as defined by the ACR Guidance Document on MR Safe Practices: 2013. The major topics covered in this video include: • Personnel designation • MR safety zones and access control • Static field • Gradient (time-varying) magnetic fields • Radio frequency (RF) fields • Spatial gradient fields • Patients with implants and/or devices • Labeling • Conditions of use (including B1+rms) • Managing patient warming • Preventing thermal injuries • Patient and non-patient screening • Quench • Medical emergencies in the MRI environment • Managing the claustrophobic or anxious patient This video program is intended to satisfy annual education requirements.

Please Note: This activity was previously offered within a combined CE Module and cannot be used again in this or any subsequent biennium if completed previously. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.  In other words if you received credit for this course last year and you are not in a new biennium, you can not take this course for credit.

Objectives

  • Define Level 1 and Level 2 MR personnel
  • Define MR safety Zones III and IV
  • Describe the procedures and documentation associated with screening non-MR personnel
  • Describe the recommendations of both the ACR and Joint Commission with regard to screening patients
  • Describe the importance of patients being dressed in MR appropriate attire prior to undergoing and MR procedure
  • Describe how to minimize the risk to patients with regard to RF burns
  • Name several methods to manage SAR during an MR procedure
  • Describe the importance of monitoring patients and how to prepare for medical emergencies
  • Name and describe the current labeling terminology for implants and devices
  • Describe safety issues related to a quench
  • Name the major acute and chronic gadolinium-based contrast media adverse events
  • Describe techniques which can minimize patient anxiety

Target Audience

The content of this Contrast Enhanced MRI Program is intended for healthcare professionals who work in the MRI environment. These individuals include MRI Technologists, Imaging Nurses, MRI Researchers, and Others.

Accreditation

This program has been approved for 1.0 hour of Category A CE credit as designated by the Society for MR Radiographers & Technologists (SMRT) RCEEM. Please Note: This activity was previously offered within a combined CE Module and cannot be used again in this or any subsequent biennium if completed previously. Additionally, this activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.

Release Date: 2/02/2022 Expiration Date: 2/02/2024

Sample